Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fingolimod in Schizophrenia
NCT01779700Phase 2Completed
- Sponsor
- Indiana University
- Start
- Jan 2013
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fingolimod in schizophrenia, schizoaffective disorder, sponsored by Indiana University. Started Jan 2013; status: completed.
02
Drugs
fingolimod
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT01779700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01779700.